J&J Innovative Medicine CarePath

The company just released its third annual report and leaders from across Janssen share some top takeaways, including a new initiative to include the list price and potential out-of-pocket costs for its most frequently prescribed medicine.

The company just released its second-annual report and we’re spotlighting the top takeaways for patients, consumers and healthcare professionals, including a look at how Janssen approaches drug pricing.